8-K 1 a17-26511_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  November 13, 2017

 

UNIVERSAL HOSPITAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-20086

 

41-0760940

(State or other jurisdiction of

 

(Commission

 

(IRS Employer

incorporation)

 

File Number)

 

Identification No.)

 

6625 West 78th Street, Suite 300

Minneapolis, Minnesota 55439-2604

(Address of principal executive offices)

(Zip Code)

 

952-893-3200

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 


 

ITEM 2.02  RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

On November 13, 2017 Universal Hospital Services, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2017.  A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

 

ITEM 7.01  REGULATION FD DISCLOSURE

 

Attached as Exhibit 99.2 to this report, and incorporated herein by reference, is a copy of the slide presentation for the investor conference call with management scheduled for November 14, 2017, to discuss Universal Hospital Services, Inc.’s announced results for the quarter ended September 30, 2017.

 

ITEM 9.01  FINANCIAL STATEMENTS AND EXHIBITS

 

(d)

 

Exhibits

99.1

 

Press release issued by Universal Hospital Services, Inc. on November 13, 2017

99.2

 

Slides presented during Universal Hospital Services, Inc.’s earnings call scheduled for November 14, 2017 of its results for the quarter ended September 30, 2017

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Universal Hospital Services, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: November 13, 2017

UNIVERSAL HOSPITAL SERVICES, INC.

 

 

 

By

/S/ James B. Pekarek

 

James B. Pekarek

 

Executive Vice President and Chief Financial Officer

 

4